Description of Sign-and-symptom Associations at Acromegaly Diagnosis. (ACRO-POLIS)

August 1, 2019 updated by: Ipsen
The purpose of this study is to describe most characteristic association of signs and symptoms present at the time of acromegaly diagnosis.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

648

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Amiens, France
        • Hopital Sud
      • Besançon, France
        • Chu Besancon Hopital Jean Minjoz
      • Brest, France
        • Hopital La Cavale Blanche
      • Caen, France
        • CHU côte de Nacre
      • Creteil, France
        • Hopital Henri Mondor
      • Grenoble, France
        • CHU de Grenoble Hopital Albert Michallon
      • Lille, France
        • Hôpital Claude Huriez
      • Limoges, France
        • Hôpital Le Cluzeau
      • Lyon, France
        • Hopital Neuro-cardiologique
      • Marseille, France
        • Hopital de la Timone
      • Montpellier, France
        • Hôpital Lepeyronie
      • Nancy, France
        • Hôpitaux de Brabois
      • Orléans, France
        • CHR Orleans - Hopital La Source
      • Paris, France
        • Hôpital Lariboisière
      • Paris, France
        • CH de Bicètre
      • Paris, France
        • CH Pitie Salpetreire
      • Pessac, France
        • Hopital Haut Leveque
      • Reims, France
        • CHU Reims - Hôpital Robert Debré
      • Rennes, France
        • Hopital Sud Anne de Bretagne
      • Rouen, France
        • CHU Rouen - Hôpital de Bois Guillaume
      • Saint Etienne, France
        • Hôptital Nord
      • Strasbourg, France
        • Hopital Civil
      • Strasbourg, France
        • Hopital de Hautepierre
      • Toulouse, France
        • Hopital Larrey
      • Tours, France
        • CHU Bretonneau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Acromegalic patients

Description

Inclusion Criteria:

  • Adult patient (greater than or equal to 18 years old)
  • Patient with acromegaly, diagnosed for less than 5 years

Exclusion Criteria:

  • Patient who have objected to the collection of his/her data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Acromegalic patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Description of the most characteristic sign-and-symptom associations of acromegaly, collected by a patient questionnaire.
Time Frame: At the time of patient diagnosis, up to 3 months
At the time of patient diagnosis, up to 3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Description of demographic and clinical characteristics of patients with acromegaly, collected by a patient questionnaire.
Time Frame: At the time of patient diagnosis, up to 3 months
At the time of patient diagnosis, up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ipsen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

November 28, 2013

First Submitted That Met QC Criteria

December 10, 2013

First Posted (Estimate)

December 16, 2013

Study Record Updates

Last Update Posted (Actual)

August 5, 2019

Last Update Submitted That Met QC Criteria

August 1, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A-54-52030-266

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acromegaly

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe